Eur J Lipid Sci Technol 122:1900350
GLP-1 drugs (also called GLP-1 agonists) are medications originally marketed to treat diabetes
If a person responds to a lower dose with good weight loss, further dose escalation may not be needed, says Kushner
Clinical trials confirmed no effect on serum IGF-1, no negative impact on carbohydrate metabolism, and excellent tolerability with safety profile indistinguishable from placebo
219 Omega-3 fatty acids Low dietary intake of the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) increases the risk for headaches 220 and migraine
What patients commonly report at each step Gastrointestinal symptoms nausea, mild vomiting, transient constipation or diarrhea are the most commonly reported experiences at any dose step, and they tend to be sharpest in the first weeks after moving to a new one